• Valera Health

  Participated · Equity · Oct 2022

  Valera Health operates a virtual behavioral healthcare practice that delivers comprehensive, longitudinal care through a team-based model of licensed therapists, nurse practitioners, case managers and psychiatrists augmented by proprietary digital technology and analytics. The company emphasizes evidence-based treatment plans and a quality strategy aligned to NCQA HEDIS measures to manage patients across acuity levels, from mild depression to schizophrenia. Valera partners closely with health systems and health plans, and its payer/provider partnerships collectively cover over 50 million lives. It offers culturally-intentional care to BIPOC and LGBTQ+ communities via a diverse, multilingual provider network in which more than 50% of clinicians self-identify as Black, Hispanic, or Asian. Valera says the financing will enable expansion of access to high-quality behavioral health care and deepen partnerships with leading health systems and health plans. The company closed a $44.5M growth equity round in late 2022 as part of its current financial position. Valera Health is a NYC-based mental health company delivering tech-driven virtual services. It provides comprehensive longitudinal care via a team-based model of coaches, therapists, and medication prescribers augmented by proprietary digital technology and analytics. The company treats conditions ranging from mild depression to severe schizophrenia and offers personalized, culturally intentional care for rural and urban communities, including BIPOC and LGBTQ+ patients, through a diverse, multilingual provider network. Over the past twelve months Valera has partnered with health plans and provider groups covering over 12 million lives. Valera intends to use the newly raised $15M to expand operations and business reach and will be expanding to multiple states in the coming months. The company is led by co-founder and CEO Dr. Thomas Tsang. Valera Health is a Brooklyn, N.Y.-based tele-behavioral health service that delivers longitudinal, team-based clinical care using coaches, therapists and medication prescribers augmented by proprietary digital technology. Its care model provides personalized treatment across a spectrum from meditation to therapy to medications for patients with mild depression to severe schizophrenia. The multidisciplinary care team includes licensed social workers, mental health counselors, nurse practitioners, and psychiatrists. The company is led by CEO and co-founder Thomas Tsang, MD. Valera plans to use new capital for strategic market expansion and to grow existing services. The articles report total funding to date of $9M following the latest raise.

• Abacus Insights

  Participated · Series C · Jun 2022

  Abacus Insights offers a comprehensive technology platform that reconciles thousands of unique attributes about individual consumers and their health to enable personalized, interoperable care for payors. The platform supports payor initiatives across value-based care, member engagement, and digital transformation. Today Abacus and its health plan clients manage data for more than 21 million unique members and 15 million consumers. The company says the Series C funds will be used to scale the business, accelerate the capabilities and connections of its technology platform, and add technology talent. The financing brings the Boston-based company’s total venture backing to $81 million. SVB Securities acted as exclusive financial advisor to Abacus Insights. Abacus Insights provides a cloud-based platform that standardizes, curates and enriches healthcare data trapped in legacy silos, combining it with hundreds of third-party sources to create complete, reliable patient records. The platform enables health plans to integrate and share data with doctors, hospitals, pharmacies, labs and digital health applications, helping plans become engines of healthcare innovation. Abacus positions this capability to support use cases from chronic disease management to wearables and wellness apps and to create an “n-of-1” personalized care experience. The company says the funds will be used to scale the business, accelerate platform capabilities and connections, and add technology talent. The announcement ties to recent federal rules outlawing information blocking and highlights demand for secure, shareable health data. The financing brings the under three-year-old Boston-based company’s total venture backing to $53 million. Abacus Insights operates a data management and integration platform tuned for the healthcare industry that aggregates patient medical history from legacy systems into a single place. The company targets large health insurance companies as customers, arguing insurers have the broadest view of a person's healthcare because payment flows through them. Abacus's platform is intended to make it easier for insurers and providers to view real-time patient data and make better care decisions, with the broader goal of lowering costs across the system. The company was launched in 2017 and is led by founder and CEO Dr. Minal Patel. Abacus has offices in Boston and New York and currently employs 40 people. Using proceeds from the round, it plans to roughly double headcount by the end of the year, focusing on adding engineering talent to further build out the product.

• Pager

  Participated · Series C · Sep 2021

  Pager operates a virtual care collaboration platform that combines AI automation with concierge services to deliver a whole-person healthcare experience. Its solution integrates triage, telemedicine, e-prescriptions, appointment scheduling, after-care follow-up, care advocacy, and customer service within an omni-channel communications interface. The platform aggregates nurses, doctors, pharmacists, coordinators, and advocates so that users can access an end-to-end care journey in one place. Pager works with payers, providers, and employers that collectively cover more than 15 million people across the United States and Latin America. The company is expanding its enterprise offering, Pager 360, which supports cross-functional care teams and is distributed through health plans, provider systems, and employers. Fresh capital will be allocated to scaling capacity for rising demand, accelerating product innovation, and entering additional U.S., Latin American, and global markets. Pager is headquartered in New York City and is led by CEO and Chairman Walter Jin.

• Zipari

  Participated · Series B · Jan 2020

  Zipari builds a consumer experience platform and a suite of more than 20 products designed for health insurance payers and third‑party administrators. The company serves nearly 200 clients and reaches more than 40 million members through its payer and TPA customers. Zipari announced a strategic growth investment from Thoma Bravo and will combine with Healthx to create an end‑to‑end CX platform for payers. Leadership will remain with Founder and CEO Mark Nathan, and the company will remain headquartered in Brooklyn, New York. Thoma Bravo said it will help accelerate Zipari’s growth strategy by strengthening client success, broadening products and driving faster innovation. Financing for the transaction was provided by certain funds and accounts managed by The Private Credit Group of Goldman Sachs Asset Management L.P. Advisors on the transaction included TripleTree (exclusive financial advisor to Zipari), Brentwood Capital Advisors (exclusive financial advisor to Healthx), Kirkland & Ellis (legal advisor to Thoma Bravo) and Goodwin Procter (legal advisor to Healthx). Zipari is a consumer experience platform built specifically for health insurance carriers, offering configurable products to engage members across channels. The company recently launched CX Engagement Hub to assign value to cross-departmental member goals and to orchestrate prioritized engagement, and it launched a Partner Network to accelerate integrated CX delivery. Zipari serves 18 health insurance carriers and more than 13 million members via its payer customers. Proceeds from the recent financing will be used to widen distribution channels, expand partner integrations, and scale development of Zipari’s product lines with focused investments in strategic innovations. Customers and investors cite Zipari's ability to integrate customer data across payer systems and enable digital engagement as central to improving member experience and reducing operational costs. Zipari is based in Brooklyn, New York. Zipari provides carriers with a CX platform: a SaaS insurance-specific consumer experience platform that delivers real-time insights into consumer behavior at every touch-point. The platform enables member segmentation using predictive analytics and delivers recommendations to optimize the user experience. Its InsureCX product offers insurers a CRM solution to gain real-time visibility into every interaction, identify cross-sell and upsell opportunities, and manage member, prospect, broker, agent and provider relations. InsureCX also visualizes data and performance insights and integrates with major CRM solutions. Zipari is led by CEO Mark Nathan and is based in Brooklyn, New York. The company raised $7M in Series A funding and intends to use the proceeds to scale adoption of its solutions. Zipari provides a white-label customer experience platform that delivers consumer navigation tools, provider lookups with ratings, a formulary app for drug coverage and price comparisons, and member sentiment analytics. Its platform captures interaction data (for example, where users abandon health questionnaires) to drive engagement and improve re-enrollment. Zipari targets CO-OPs and small-to-midsized carriers initially, with plans to pursue large carriers later. The company emphasizes health literacy features to help newly insured consumers navigate coverage. It was started about 10 months prior to the article and has doubled headcount from 10 to roughly 20 employees. Management projects adding 30–40 employees with recent funding and growing to about 110 employees by 2017.

• AbleTo

  Participated · Series D · Aug 2017

  AbleTo provides an eight-week, personalized behavioral-health program where plan members complete a questionnaire and are matched with a behavioral health coach and a therapist via phone or video. The company works primarily with self-insured employers and health plans to identify and treat people who report depression, anxiety, or stress. AbleTo says its approach can improve workplace outcomes; an Aetna study of members with cardiovascular disease and depression found program graduates experienced a 61% drop in absenteeism and a 44% decline in working while sick. Management plans to continue clinical research validating its approach in depression, anxiety and diabetes, and to explore applying the platform to patients newly diagnosed with chronic conditions. Another priority is adding telepsychiatry services, after finding 20–30% of patients need some form of telepsychiatry consult. The company intends to use new funding to expand its customer base.

No current team members are available.